{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:08:29Z","timestamp":1785578909700,"version":"3.56.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139671","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T18:01:47Z","timestamp":1443808907000},"page":"e0139671","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge"],"prefix":"10.1371","volume":"10","author":[{"given":"Na Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Suk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeung Haeng","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Myung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"RJ Collier","year":"2003","journal-title":"Annu Rev Cell Del Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation","volume":"76","author":"JAT Young","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mam.2009.07.003","article-title":"Cellular and systemic effects of anthrax lethal toxin and edema toxin","volume":"30","author":"M Moayeri","year":"2009","journal-title":"Mol Asp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1462-5822.2006.00866.x","article-title":"Contribution of toxins to the pathogenesis of inhalational anthrax","volume":"9","author":"JN Tournier","year":"2007","journal-title":"Cellular Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.micinf.2011.07.005","article-title":"Key aspects of the molecular and cellular basis of inhalational anthrax","volume":"13","author":"CK Cote","year":"2011","journal-title":"Microbes Infect"},{"key":"ref6","first-page":"313","article-title":"Membrane translocation by anthrax toxin","volume":"30","author":"RJ Collier","year":"2009"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e13888","DOI":"10.1371\/journal.pone.0013888","article-title":"Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism","volume":"5","author":"AF Kintzer","year":"2010","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/bi015860m","article-title":"Stoichiometry of anthrax toxin complexes","volume":"41","author":"J Mogridge","year":"2002","journal-title":"Biochem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1164\/rccm.201102-0209CI","article-title":"Anthrax infection","volume":"184","author":"DA Sweeney","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1462-5822.2003.00318.x","article-title":"Innate immunity and biodefense vaccines","volume":"5","author":"NM Valiante","year":"2003","journal-title":"Cellular Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","article-title":"Anthrax vaccination strategies","volume":"30","author":"RJ Cybulski","year":"2009","journal-title":"Mol Asp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"20","author":"ML Pitt","year":"2001","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"S Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"ED Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccine: an historical perspective and view to the future","volume":"239","author":"MA Liu","year":"2011","journal-title":"Immunological Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.addr.2005.01.013","article-title":"DNA vaccines for biodefence","volume":"57","author":"HS Garmory","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time","volume":"9","author":"MA Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with DNA plasmid encoding anthrax protective antigen","volume":"17","author":"ML Gu","year":"1999","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"G Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"D Galloway","year":"2004","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/sj.mt.6300286","article-title":"Immunization by application of DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage","volume":"15","author":"DS Shaker","year":"2007","journal-title":"Mol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy terminal domain of the protective antigen of <italic>Bacillus anthracis<\/italic> protects mice against anthrax infection","volume":"70","author":"HC Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody responses to <italic>Bacillus anthracis<\/italic> protective antigen domain IV by use of calreticulin as achimeric molecular adjuvant","volume":"76","author":"YS Park","year":"2008","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-0556-9-13","article-title":"Biodistribution and blood clearance of plasmid DNA administration in arginine peptide complexes","volume":"9","author":"JG Woo","year":"2011","journal-title":"Gen Vaccine Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jbiotec.2005.11.014","article-title":"Absolute and relative QPCR quantification of plasmid copy number in <italic>Escherichia coli<\/italic>","volume":"123","author":"C Lee","year":"2006","journal-title":"J Biotech"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-1759(03)00223-0","article-title":"A method for the absolute quantification of cDNA using real-time PCR","volume":"278","author":"JA Whelan","year":"2003","journal-title":"J Immunol Meth"},{"key":"ref27","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/JVI.72.2.1497-1503.1998","article-title":"Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage","volume":"72","author":"S Andre","year":"1998","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/JVI.74.6.2628-2635.2000","article-title":"Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene","volume":"74","author":"J Megede","year":"2000","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/JVI.74.13.5997-6005.2000","article-title":"Enhancement of primary and secondary cellular responses induced against human immunodeficiency virus Type 1 gag by using DNA expression vectors that target gag antigen to the secretory pathway","volume":"74","author":"JT Qiu","year":"2000","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0006-291X(03)00795-2","article-title":"High-level expression of human glycosyltransferases in insect cells as biochemically active form","volume":"305","author":"HG Kim","year":"2003","journal-title":"Biochem Biophy Res Comm"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/CVI.00071-06","article-title":"Expression of bovine viral diarrhea glycoprotein E2 as a soluble secreted form in a mammalian cell line","volume":"13","author":"G Donofrio","year":"2006","journal-title":"Clin Vaccine Immuno"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.vaccine.2010.08.107","article-title":"Distinct immune responses of recombinant plasmid DNA replican vaccines expressing two types of antigens with or without signal sequences","volume":"28","author":"YZ Yu","year":"2010","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0006-291X(02)02486-5","article-title":"Electroporation in combination with plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle","volume":"289","author":"P Blomberg","year":"2002","journal-title":"Biochem Biophy Res Comm"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.gt.3301419","article-title":"Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid","volume":"8","author":"S Li","year":"2001","journal-title":"Gene Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1586\/erv.09.132","article-title":"DNA vaccines for biodefense","volume":"8","author":"LC Dupuy","year":"2009","journal-title":"Expert Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","article-title":"Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA coding DNA vaccine in rhesus macaques","volume":"28","author":"BD Livingston","year":"2010","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1046-5928(02)00612-5","article-title":"Expression and purification of the <italic>Bacillus anthracis<\/italic> protective antigen domain 4","volume":"27","author":"S Krishnanchettiar","year":"2003","journal-title":"Protein Expr Purif"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"12","author":"L Li","year":"2012","journal-title":"J Biotech"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.vaccine.2008.03.064","article-title":"Potentiation of an anthrax DNA vaccine with electroporation","volume":"26","author":"A Luxembourg","year":"2008","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/IAI.02029-06","article-title":"Identification of in vivo expressed immunogenic proteins by serological proteome analysis of <italic>Bacillus anthrasis<\/italic> secretome","volume":"75","author":"T Chitlaru","year":"2007","journal-title":"Infect Immun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1016\/j.vaccine.2005.06.029","article-title":"Tissue distribution of a plasmid DNA containing epitopes of foot-and-mouth disease virus in mice","volume":"23","author":"HY Zhang","year":"2005","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jgm.1138","article-title":"Biodistribution and expression of targeted fusion anti-caries DNA vaccine pGJA-P\/VAX in mice","volume":"10","author":"C Liu","year":"2008","journal-title":"J Gene Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF02977618","article-title":"In vivo kinetics and biodistribution of HB-110, a novel HBV DNA vaccine after administration in mice","volume":"30","author":"ES Kang","year":"2007","journal-title":"Arch Pharm Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to <italic>Bacillus anthracis<\/italic>","volume":"51","author":"SL Welkos","year":"1986","journal-title":"Infect Immun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:18:24Z","timestamp":1599625104000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139671"}},"subtitle":[],"editor":[{"given":"Adam","family":"Driks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139671","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}